Table 2.
Clinical data referred to the validation cohort of patients.
| Characteristic | Distribution |
|---|---|
| Outcome | |
| DF cases (%) | 8 (72.7%) |
| non-DF cases (%) | 3 (27.3%) |
| Gender | |
| Male (%) | 3 (27.3%) |
| Female (%) | 8 (72.7%) |
| Tumor site | |
| Trunk (%) | 5 (45.5%) |
| Extremities (%) | 3 27.3%) |
| Head & neck (%) | 1 (9.1%) |
| Other (%) | 2 (18.2%) |
| Stage | |
| I (%) | 2 (18.2%) |
| II (%) | 9 (81.8%) |
| T | |
| T2 (%) | 2 (18.2%) |
| T3 (%) | 4 (36.3%) |
| T4 (%) | 5 (45.5%) |
| Age | |
| Median (std.) | 56.0 (13.2) |
For categorical variables, percentage (%) counts are reported. For continuous values, the median and standard deviation (sd.) values are indicated. The tumor site labelled as ‘Other’ was the gluteus muscle for both patients.